Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236596 · ClinicalTrials.gov registry record · NA
Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04236596 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 22 participants.
The verdict
NCT04236596, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study is to map the pudendal nerve. In this study the researchers will examine subjects who are already receiving an implanted stimulator at their pudendal nerve as part of their normal clinical care.
Interventions
- DEVICE Participants received a Neurostimulator, which was used to map the pudendal nerve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2023-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04236596
The ClinicalTrials.gov registry entry for NCT04236596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Participants received a Neurostimulator, which was used to map the pudendal nerve is the first listed.
NCT04236596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04236596 about?
NCT04236596 is a clinical study titled "Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention". This study is to map the pudendal nerve. In this study the researchers will examine subjects who are already receiving an implanted stimulator at their pudendal nerve as part of their normal clinical care.
What is the current status of trial NCT04236596?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-09-14. Estimated completion is 2023-06-08.
What interventions are being tested in trial NCT04236596?
The interventions under investigation include: Participants received a Neurostimulator, which was used to map the pudendal nerve (DEVICE).
Who is sponsoring clinical trial NCT04236596?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.